At1g55890 Antibody

What is At1g55890 and why is it significant for antibody research?

At1g55890 is a gene in Arabidopsis thaliana encoding a Tetratricopeptide repeat (TPR)-like superfamily protein that functions as a ribosomal pentatricopeptide repeat protein. It has significance in plant molecular biology research as part of the TPR-like superfamily, which plays important roles in protein-protein interactions and the assembly of multiprotein complexes . Antibodies targeting this protein or its modifications allow researchers to study its expression, localization, and function in plant cellular processes.

What types of antibodies are available for At1g55890 research?

Based on available research resources, antibodies for At1g55890 research include custom polyclonal antibodies developed by commercial providers like Cusabio (product code: CSB-PA862782XA01DOA) . Additionally, researchers studying histone modifications in chromatin regions containing At1g55890 may utilize antibodies such as anti-H3K4me3 (histone H3 trimethylated lysine 4) antibodies, which can be used to study chromatin state and gene expression regulation in regions containing this gene .

What are the common applications for At1g55890 antibodies?

At1g55890 antibodies and related antibodies such as anti-H3K4me3 can be used in multiple experimental applications including:

• Chromatin Immunoprecipitation (ChIP) - For studying protein-DNA interactions

• ChIP-seq - For genome-wide mapping of protein binding sites

• Western blotting - For protein detection and quantification

• Immunofluorescence (IF) - For protein localization studies

• ELISA - For quantitative detection of target proteins

• Dot blot analysis - For antibody specificity testing

• Peptide array analysis - For epitope mapping and cross-reactivity assessment

How should At1g55890 antibodies be stored and handled?

For optimal performance and longevity, antibodies should be stored according to manufacturer recommendations. Generally, antibodies should be stored in aliquots at -20°C to avoid repeated freeze-thaw cycles that can degrade antibody quality. Before use, tubes should be briefly spun to ensure no material is lost due to adhesion to tube walls or caps. Liquid formulations are typical, though some may be provided lyophilized and require reconstitution .

How should ChIP experiments be designed using At1g55890-related antibodies?

When designing ChIP experiments using antibodies related to At1g55890 research:

• Use appropriate amount of antibody - Titration experiments with 1, 2, 5, and 10 μg of antibody per ChIP experiment may be necessary to determine optimal conditions

• Include proper controls - Use IgG (2 μg/IP) as a negative IP control

• Select appropriate primers - Design primers for positive control regions (e.g., promoters of active genes) and negative control regions (e.g., inactive genes or repetitive regions)

• Quantify recovery - Express results as percentage of input (relative amount of immunoprecipitated DNA compared to input DNA after qPCR analysis)

• Use sufficient starting material - Typically, sheared chromatin from 1 million cells is recommended

What are the recommended dilutions for different experimental applications?

Based on research with similar antibodies used in At1g55890 research contexts, the following dilutions are recommended:

These dilutions should be optimized for each specific antibody and experimental setup .

How can antibody specificity be verified for At1g55890 research?

Antibody specificity can be verified through multiple approaches:

• Peptide array analysis - Testing the antibody against arrays containing various peptides with different modifications to ensure specific binding to the target epitope

• Dot blot analysis - Spotting different amounts (100 to 0.2 pmol) of target and non-target peptides on a membrane to assess cross-reactivity

• Western blot - Testing the antibody against cell/tissue lysates to confirm it detects a protein of the expected molecular weight

• Negative controls - Including samples lacking the target protein or using non-specific IgG as control antibodies

• Blocking peptide competition - Pre-incubating the antibody with blocking peptides to demonstrate specific binding

How can ChIP-seq be optimized for At1g55890 chromatin studies?

For optimal ChIP-seq experiments investigating At1g55890 chromatin contexts:

• Library preparation - Follow manufacturer's protocols for library preparation after immunoprecipitation

• Sequencing depth - Ensure sufficient sequencing depth (typically 36bp or longer tags) for comprehensive genome coverage

• Alignment - Use appropriate algorithms (e.g., ELAND) to align sequencing reads to the reference genome

• Peak calling - Employ robust peak-calling algorithms to identify enriched regions

• Visualization - Analyze peak distribution along complete sequences and specific regions of interest

• Validation - Confirm enrichment at control regions (e.g., promoters of active genes for H3K4me3)

• Replicate experiments - Perform at least three biological replicates to ensure reproducibility and allow statistical analysis

What approaches can resolve detection challenges with At1g55890 antibodies?

When faced with detection challenges (as noted in some research where "detection of the proteins in vivo or by immunolocalization with anti-GFP antibodies was not possible" ), consider these approaches:

• Epitope accessibility assessment - Evaluate whether the target epitope might be masked in certain experimental conditions

• Fixation optimization - Test different fixation protocols that may better preserve epitope structure

• Signal amplification - Employ signal amplification techniques such as tyramide signal amplification

• Alternative antibodies - Test antibodies raised against different epitopes of the same protein

• Fusion protein strategies - Consider alternative tags or fusion strategies if GFP-based detection is problematic

• Sample preparation modifications - Adjust protein extraction or tissue preparation methods to improve epitope exposure

• Cross-linking optimization - Modify cross-linking conditions to better preserve protein-protein interactions while maintaining epitope accessibility

How can antibodies be used to study At1g55890 function in chromatin remodeling?

For studying At1g55890's role in chromatin dynamics:

• Sequential ChIP (re-ChIP) - Perform consecutive immunoprecipitations with different antibodies to identify co-occurrence of different proteins or modifications

• ChIP followed by mass spectrometry - Identify protein complexes associated with chromatin regions containing At1g55890

• Chromosome conformation capture techniques (3C, 4C, Hi-C) combined with ChIP - Study the three-dimensional organization of chromatin in regions containing At1g55890

• CRISPR-based techniques combined with antibody detection - Use CRISPR to modify At1g55890 and study the effects on chromatin structure using antibodies against histone modifications

• Time-course experiments - Apply antibodies to study dynamic changes in chromatin state at different developmental stages or under different environmental conditions

What are the considerations for cross-species applications of At1g55890 antibodies?

When applying At1g55890 antibodies across different plant species:

• Sequence homology analysis - Compare sequence homology of the target epitope across species to predict potential cross-reactivity

• Epitope conservation assessment - Determine if the epitope recognized by the antibody is conserved in other species

• Validation in each species - Always validate antibody performance in each new species before proceeding with full experiments

• Blocking peptide controls - Use blocking peptides specific to each species to confirm specificity

• Western blot verification - Perform Western blots on protein extracts from different species to confirm the detected protein is of the expected molecular weight

• Consider raising species-specific antibodies if cross-reactivity is inadequate

How should contradictory ChIP-seq data for At1g55890 chromatin regions be resolved?

When faced with contradictory ChIP-seq data:

• Experimental conditions review - Compare experimental conditions, antibody lots, and protocols used in different experiments

• Biological variability assessment - Consider whether differences might reflect genuine biological variability rather than technical issues

• Statistical analysis - Apply robust statistical methods to determine if differences are statistically significant

• Control region examination - Check results at established control regions to validate each experiment

• Sequencing depth analysis - Assess whether differences might be due to insufficient sequencing depth in one dataset

• Peak calling parameters - Review peak calling parameters and algorithms used in each analysis

• Orthogonal validation - Use alternative techniques (e.g., ChIP-qPCR, ATAC-seq) to validate findings

• Integration with other data types - Correlate ChIP-seq data with RNA-seq, methylation data, or other relevant datasets to provide context

What factors might affect antibody performance in plant chromatin studies?

Several factors can influence antibody performance in plant chromatin studies:

• Plant tissue fixation - Plants have cell walls that may impede fixative penetration, requiring optimization

• Secondary metabolites - Plant tissues contain various secondary metabolites that may interfere with antibody binding

• Sample preparation - Grinding methods and buffer composition need optimization for plant tissues

• Chromatin complexity - Plant genomes may have unique features affecting chromatin accessibility

• Crosslinking conditions - Different tissues may require different crosslinking times and conditions

• Antibody specificity - Plant-specific modifications may affect epitope recognition

• Endogenous peroxidases - Plants contain endogenous peroxidases that may cause background in detection systems using peroxidase-conjugated secondary antibodies

How can At1g55890 antibody data be integrated with other omics approaches?

For comprehensive understanding of At1g55890 function, integrate antibody-based data with:

• Transcriptomics (RNA-seq) - Correlate protein localization/modification with gene expression patterns

• Proteomics - Identify interaction partners and post-translational modifications

• Metabolomics - Link chromatin changes to downstream metabolic effects

• Phenomics - Connect molecular findings to observable phenotypes

• Systems biology modeling - Develop predictive models incorporating antibody-derived data with other omics layers

• Machine learning approaches - Apply machine learning to identify patterns across multiple omics datasets

• Visualization tools - Utilize genome browsers and other visualization tools to integrate different data types

How might antibody engineering enhance At1g55890 research?

Advanced antibody engineering approaches that could benefit At1g55890 research include:

• Single-domain antibodies - Developing smaller antibody fragments with improved tissue penetration

• Recombinant antibody production - Creating precisely engineered antibodies with consistent performance

• Epitope-specific design - Engineering antibodies to recognize specific post-translational modifications of At1g55890

• Bifunctional antibodies - Developing antibodies that can simultaneously bind to multiple targets

• Intrabodies - Engineering antibodies that function within living cells for real-time imaging

• Nanobodies - Using camelid-derived single-domain antibodies for applications requiring smaller probes

• Affinity maturation - Improving binding affinity and specificity through directed evolution approaches

What emerging technologies could overcome current limitations in At1g55890 antibody research?

Emerging technologies that could advance At1g55890 antibody research include:

• CUT&RUN and CUT&TAG - More sensitive alternatives to traditional ChIP for detecting protein-DNA interactions

• Single-cell technologies - Applying antibodies in single-cell analyses to understand cell-to-cell variation

• Spatial transcriptomics combined with immunofluorescence - Correlating protein localization with gene expression in intact tissues

• CRISPR-based techniques - Using CRISPR for precise genome editing to study At1g55890 function

• Mass cytometry - Enabling simultaneous detection of multiple proteins in single cells

• Proximity labeling - Using enzyme-antibody fusions to identify proteins in close proximity to At1g55890

• Optogenetics combined with antibody detection - Controlling protein activity with light and monitoring effects with antibodies